IHM
KPTI icon

Iguana Healthcare Management’s Karyopharm Therapeutics KPTI Stock Holding History

Iguana Healthcare Management’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.68M Sell
8,333
-11,667
-58% -$2.33M 1.1% 38
2017
Q4 		$2.88M Sell
20,000
-6,667
-25% -$1.07M 1.88% 18
2017
Q3 		$4.39M Buy
26,667
+6,667
+33% +$955K 2.39% 14
2017
Q2 		$2.71M Buy
20,000
+1,667
+9% +$247K 1.53% 28
2017
Q1 		$3.53M Buy
+18,333
New +$2.94M 1.75% 18

Other funds holding KPTI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Iguana Healthcare Management's KPTI Position: Q1 2018 in Review

Iguana Healthcare Management reduced its Karyopharm Therapeutics (KPTI) stake by 58% in Q1 2018, selling an estimated $2.33M and leaving 8,333 shares worth $1.68M. The position accounts for 1.1% of the portfolio, ranked #38.

Iguana Healthcare Management first reported a position in KPTI in Q1 2017 and has held it in 5 quarters since. The position peaked at $4.39M in Q3 2017. 88 funds tracked by Wall St. Rank hold KPTI as of Q1 2018.

  • Iguana Healthcare Management held 8,333 shares of Karyopharm Therapeutics worth $1.68M as of Q1 2018.
  • Iguana Healthcare Management sold 11,667 Karyopharm Therapeutics shares in Q1 2018, an estimated $2.33M.
  • Karyopharm Therapeutics made up 1.1% of Iguana Healthcare Management's portfolio in Q1 2018, its #38 holding.
  • Iguana Healthcare Management first reported a position in Karyopharm Therapeutics in Q1 2017 and has held it in 5 quarters since.
  • Iguana Healthcare Management's Karyopharm Therapeutics position peaked at $4.39M in Q3 2017.
  • 88 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.